Background: Hearing loss or hearing impairment is a clinically and genetically heterogeneous disorder. More than 117 genes were discovered to date in hereditary, nonsyndromic hearing loss (NSHL). Identifying novel gene variants and their frequency in specific populations is valuable for public health and potentially for genetic screening of NSHL. Aims: To identify the gene variants underlying NSHL in a Pakistani cohort. Methods and Results: A cohort of 40 school-aged children with NSHL was initially screened for variants in GJB2, the gene with the highest incidence of variants in other populations with NSHL. We found known homozygous as well as compound heterozygous GJB variants in 15 individuals. Next, we used targeted next generation sequencing (TNGS) for the remaining 25 individuals and identified 20 different variants in 14 genes (SLC26A4, KCNQ4, MYO7A, MYO15A, TMPRSS3, ESPN, TMC1, GIPC3, LHFPL5, WFS1, DFNB59, GRXCR1, ESRRB, and LRTOMT). Conclusions: We described common and novel variants in 15 genes in a Pakistani cohort of NSHL.
To the Editor: Hearing loss is a clinically and genetically heterogeneous disorder and is the most common human disability (Shrivastava, Shrivastava, & Ramasamy, 2016) . Both environmental and genetic factors were shown in the pathogenesis of hearing loss such as iodine deficient diet, infections, ototoxic drug treatment, or gene variants (http://hered itary heari ngloss.org/) (Morton & Nance, 2016; Shrivastava et al., 2016; Wonkam et al., 2013) . Nonsyndromic hearing loss (NSHL) can be inherited as an autosomal recessive (AR), autosomal dominant (AD), X-linked (dominant or recessive), or mitochondrial trait (Liu et al., 2005; Snoeckx et al., 2005; Wang, Han, Khan, & Zhang, 2017) . Identifying novel sequence variants in populations provide valuable information for public health, particularly for genetic screening of the NSHL.
In our study, we recruited a total of 40 unrelated individuals affected by NSHL from Bannu and Kohat districts in Khyber Pakhtunkhwa (KPK) province, Pakistan. A clinical questionnaire was used to collect medical history and rule out the history of other diseases potentially affecting hearing and environmental factors such as antibiotic use, excessive noise exposure, and infection that could cause hearing loss. Detailed physical examination did not reveal other abnormal findings than hearing loss. Palpable goiters and other dysmorphic features were not observed in any of the participants with hearing loss; their hearing was ranging from severely impaired to deaf, listed in Figure 1 and Table 1 . All of the probands had bilateral, prelingual hearing loss consistent with a congenital origin. There was no previous family history of hearing loss in the participants. The study design and protocol were approved by the Institutional Review Board of (IRB) Quaid-i-Azam University Islamabad Pakistan, the Ethical Review Committee (ERC) of Peking Union Medical College (Beijing, China), and China Medical University (Shenyang, China). Written informed consents to conduct and publish the study were obtained from all participating individuals and their parents. All 40 individuals were screened by polymerase chain reaction (PCR) and Sanger sequencing for variants in GJB2 (gap junction protein beta 2; NM_004004.5) gene which is the most commonly mutated gene in recessive NSHL (Liu et al., 2005; Snoeckx et al., 2005 Table 1) . The 25 individuals, who were negative for GJB2 gene variants, were screened by targeted next generation sequencing (TNGS) technology using the Ion Torrent platform for a panel of 63 genes implicated in hearing loss as described previously (Wang et al., 2017) . We identified 20 variants in 14 genes (SLC26A4, KCNQ4, MYO15A, TMPRSS3, ESPN, TMC1, GIPC3, LHFPL5, WFS1, DFNB59, GRXCR1, ESRRB, and LRTOMT) . Ten were novel such as two homozygous missense variant in MYO15A c. Table 1 ). The functional effect of the variants was predicted using the in silico tools including Polyphen2 (http://genet ics.bwh.harva rd.edu/pph2/), Sorting Intolerant from Tolerant (SIFT) (http://sift.jcvi.org/), PROVEAN (http:// www.prove an.jcvi.org) Mutation Taster (http://www.mutat ionta ster.org/), Human Splicing Finder (HSF) (http://www.umd.be/ HSF) and CADD (https ://cadd.gs.washi ngton.edu) (Table 1) .
Furthermore, these novel variants was neither present in the dbSNP (http://www.ncbi.nlm.nih.gov/SNP/),Exome Variant Server (http://evs.gs.washi ngton.edu/EVS/), GnomAD (https ://gnomad.broad insti tute.org), Human gene mutation database (HGMD, http://www.hgmd.cf.ac.uk/ac/index.php), 1,000 Genomes (http://www.1000g enomes.org/), and Exome aggregation consortium (ExAC) (http://www.exac.broad insti tute. org). Finally, for the interpretation of variants, the American College of Medical Genetics and Genomics (ACMG) 2015 guidelines were used (Table 1) (Richards et al., 2015) .
None of the novel variants were present in 200 ethnically matched control individuals confirmed by PCR and Sanger sequencing. The '15 of 40 patients had known variants in GJB2 (described above), 5 of 40 patients had known variants in SLC26A4 c.679G > C; p.Ala227Pro, 3 of 40 had known variants in MYO7A c.1258A > T; p.Lys420*, c.4838delA; p.Asp1613Valfs*32, 2 of 40 had known variants in GRXCR1 c.784C > T; p.Arg262*, 2 of 40 had known variants in TMPRSS3 c.727G > A; p.Gly243Arg, c.1219T > C; p.Cys407Arg, 2 of 40 had known variants in WFS1 c.2338G > A; p.Gly780Ser, c.2590G > A; p.Glu864Lys, 1 of 40 had known variant in ESPN c.2519G > A; p.Trp840*,1 of 40 had known variant in LRTMOT c.154C > T; p.Arg52Trp and were already known to be associated with syndromic or NSHL (Salman et al., 2015; Wang et al., 2017) . The GJB2 variants were the most common variants in our patient cohort. Our study showed that GJB2 is the most common gene found mutated in our Pakistani cohort which is similar to other cohorts around the world (Salman et al., 2015; Snoeckx et al., 2005; Wang et al., 2017 (Salman et al., 2015) .
In our patient cohort we found 15/40 patients had GJB2 variants, (5/40) had SLC26A4, and (3/40) had MYO7A variants responsible for NSHL. We found the incidence of GJB2 variants is higher compared to other populations. While this would argue for screening for GJB2 variants in the first place, we found a comparably high incidence for SLC26A4 and MYO7A variants together. Future research could specifically take advantage of using TNGS in the Pakistani cohort to capture a larger proportion of NSHL cases of genetic origin. We expect our study will enhance public awareness toward this hearing loss trouble and genetic counseling significance for the affected families and their members. This study expanded a spectrum of disease causing variants in genes involved in causing hearing loss. T A B L E 1 (Continued) 
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